Our medical establishment told people to "Stop Trusting the Public Health Establishment". Now, almost no one trusts our ...

Vaccine boosters help keep cancer patients from being hospitalized or admitted to intensive care units due to COVID-19, according to a new study led by Cedars-Sinai investigators.

Tocilizumab significantly reduced 28-day mortality and length of ICU stay in patients with severe COVID-19 pneumonia and low S-spike nAb titers.

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

Many patients experience long-lasting health problems after COVID-19. The study aimed to assess 3-year trajectories of a comprehensive set of patient-reported outcome measures (PROMs) in patients ...

Added value of this study To the best of our knowledge, this study is the largest randomised clinical trial assessing the effect of hydroxychloroquine versus placebo added to a standard of care ...

There will probably never be a perfect treatment to cure COVID-19—but the right medications for the right patients can save lives.